Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications coronary ct angiography new onset stable chest pain editorial comment
… deep vein thrombosis, venous thromboembolism, acute coronary syndrome, hypertension, stroke, atherosclerosis, …
… Therapeutic areas in which she has worked include chronic pain (diabetic peripheral neuropathy, fibromyalgia, osteoarthritis, postherpetic pain, and lower back pain), neuroscience (insomnia and excessive daytime …
… FDA approval, clearance, or licensure of the product or new use Product pricing information Patient utilization … (e.g., the status of any study in which a product or new use is being investigated, how it relates to the overall … from Phase 1, Phase 2, and Phase 3 studies (peer-reviewed publications; congress abstracts, posters, and presentations; …
… being felt – the first 10 drugs have been selected for the new Medicare Drug Price Negotiation Program. The European … (HTAR) is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as … diseases will be introduced from January 2028 and for all new medicines starting January 2030. And yes: line or label …
… a racial or ethnic minority. However, clinical trials for new drugs predominantly involve White participants, making up … must include the DAP with the relevant Investigational New Drug (IND) application as soon as practicable. This … allows sponsors to adjust DAPs based on FDA feedback or new insights, ensuring these plans evolve appropriately …
… being felt – the first 10 drugs have been selected for the new Medicare Drug Price Negotiation Program. The European … assessment is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as … diseases will be introduced from January 2028 and for all new medicines starting January 2030. And yes, line or label …
… of results Support for scientific presentations and publications And each step will be delivered with the rigor …
… a reality. The first 10 drugs have been selected for the new Medicare Drug Price Negotiation Program and have begun … (HTAR) is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as … in January 2028. And finally, regulation for all new medicines will start in January 2030. This has left some …
… evidence-based messages that demonstrate what your new product brings to the market and how it will be …
… Papilloma Virus Infertility Menopause Osteoporosis Pelvic pain Sexual dysfunction Uterine fibroids Vaginal atrophy …